|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | |
| C07H 21/04 | |||
| A61K 31/7088 |
| (11) | Patento numeris | 1819365 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05853546.9 |
| Europos patento paraiškos padavimo data | 2005-12-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-08-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/044662 |
| Data | 2005-12-09 |
| (87) | Numeris | WO 2006/063252 |
| Data | 2006-06-15 |
| (30) | Numeris | Data | Šalis |
| 634849 P | 2004-12-09 | US |
| (72) |
DE FOUGEROLLES, Antonin, US
|
| (73) |
Alnylam Pharmaceuticals Inc.,
300 Third Street, Cambridge, MA 02142,
US
Hartmann, Gunther, Noestrasse 19, 81479 München, DE Hornung, Veit, Martinshofstr. 16, 82049 Pullach, DE Endres, Stefan, Osterwaldstrasse 58, 80805 München, DE |
| (54) | Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs |
| Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs |